Chris Vernall

Chris is an analytical chemist by training and holds a Master’s Degree from Loughborough University. He started his career at Pfizer as a Materials Scientist working on novel inhaled compounds, before moving to Nanopharm where he worked in formulation, specifically with DPIs and pMDIs. He then joined Intertek as a Senior Analyst and then moved into the commercial team as a Business Development Manager in 2014, followed by his current role as Business Development Director as of 2018.